Form 4: Progyny Director Acquires Stock Options and RSUs

Progyny, Inc. Director Elizabeth D. Bierbower acquired stock options and restricted stock units (RSUs) on May 21, 2026, as detailed in a Form 4 filing.

Summary

• Director Elizabeth D. Bierbower acquired 5,660 shares of common stock underlying restricted stock units (RSUs) on May 21, 2026. These RSUs represent a contingent right to receive one share of common stock.
• The RSUs will vest on the earlier of May 21, 2027, or the day before the Issuer's first annual meeting of stockholders following the grant date, provided the Reporting Person continues to be employed.
• Additionally, Bierbower acquired stock options to purchase 3,203 shares at an exercise price of $24.69, with an expiration date of May 20, 2036.
• These options were granted in lieu of an annual cash retainer of $39,990 for board and committee service.
• The shares subject to these options will vest on the earlier of May 21, 2027, or the day before the Issuer's first annual meeting of stockholders following the grant date, subject to continued service.
• Bierbower also acquired stock options to purchase 27,119 shares at an exercise price of $24.69, with an expiration date of May 20, 2036.
• The shares subject to these options will vest on the earlier of May 21, 2027, or the day before the Issuer's first annual meeting of stockholders following the grant date, subject to continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard equity compensation for a director, indicating alignment of interests rather than a significant financial event.

Positives

• Director acquisition of equity awards indicates confidence in the company's future prospects.
• The acquisition of stock options and RSUs aligns the director's interests with those of shareholders.
• The transaction involves a significant number of equity awards, suggesting a substantial commitment.

Negatives

• The filing details acquisitions, not sales, so there are no immediate negative financial implications from this specific transaction.
• The value of the RSUs and options is contingent on future vesting and stock performance.

Risks

• Vesting of RSUs and stock options is subject to continued service, meaning forfeiture is possible if the director leaves the company before the vesting date.
• The value of the acquired securities is subject to market fluctuations and the future performance of Progyny, Inc.

Future Outlook

The future outlook for the acquired RSUs and stock options is dependent on the continued service of the reporting person and the future performance of Progyny, Inc.'s stock price. Vesting is tied to specific dates and company events.

Industry Context

StockSavvy.ai notes that the issuance of stock options and RSUs to directors is a common practice in the technology and healthcare services sectors, including companies like Progyny, Inc., to incentivize long-term performance and align executive interests with shareholders.

Related Party Transactions

• The acquisition of stock options was made in lieu of an annual cash retainer for board and committee service, representing a form of compensation to a related party (director).

Stakeholder Impact

• Shareholders: The alignment of director compensation with stock performance can be viewed positively, as it incentivizes long-term value creation.
• Employees: This filing does not directly impact employees, but it reflects standard compensation practices for executive and board members.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Continued service by Director Elizabeth D. Bierbower to meet vesting requirements for RSUs and stock options.
• Monitoring of Progyny, Inc.'s stock performance to determine the ultimate value of the acquired equity awards.

Key Dates

Keywords

Progyny, PGNY, Form 4, SEC Filing, Stock Options, RSUs, Director Compensation, Beneficial Ownership, Equity Awards, Securities Transaction